Clinical Impact of Antibodies against Ustekinumab in Psoriasis: An Observational, Cross-Sectional, Multicenter Study. (2020)
Attributed to:
MICA: Psoriasis Stratification to Optimise Relevant Therapy (PSORT)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jid.2020.03.957
PubMed Identifier: 32283057
Publication URI: http://europepmc.org/abstract/MED/32283057
Type: Journal Article/Review
Volume: 140
Parent Publication: The Journal of investigative dermatology
Issue: 11
ISSN: 0022-202X